Evidence map›Paper›PMID 30777852›Full record

ArticleCancer research2019

Optical Radiomic Signatures Derived from Optical Coherence Tomography Images Improve Identification of Melanoma.

Zahra Turani, Emad Fatemizadeh, Tatiana Blumetti, Steven Daveluy, Ana Flavia Moraes, Wei Chen, Darius Mehregan, Peter E Andersen, Mohammadreza Nasiriavanaki

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Zahra TuraniDepartment of Electrical Engineering, Sharif University of Technology, Tehran, Iran.
Emad FatemizadehDepartment of Electrical Engineering, Sharif University of Technology, Tehran, Iran.
Tatiana BlumettiCutaneous Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil.
Steven DaveluyDepartment of Dermatology, School of Medicine Wayne State University, Detroit, Michigan.
Ana Flavia MoraesCutaneous Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil.ORCID 0000-0003-2088-7908
Wei ChenDepartment of Oncology, Karmanos Cancer Institute, Detroit, Michigan.
Darius MehreganCutaneous Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil.
Peter E AndersenDepartment of Health Technology, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0002-3134-5453
Mohammadreza NasiriavanakiDepartment of Biomedical Engineering, Wayne State University, Detroit, Michigan. mrn.avanaki@wayne.edu.ORCID 0000-0002-1437-8456
AC Camargo Hospital · BRSharif University of Technology · IRWayne State University · USTechnical University of Denmark · DKThe Barbara Ann Karmanos Cancer Institute · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Jennifer L Beebe-Dimmer · 1985 to 2026
$68.4M
NCI NIH HHS P30 CA022453
6 · The paper itself

Abstract

The current gold standard for clinical diagnosis of melanoma is excisional biopsy and histopathologic analysis. Approximately 15-30 benign lesions are biopsied to diagnose each melanoma. In addition, biopsies are invasive and result in pain, anxiety, scarring, and disfigurement of patients, which can add additional burden to the health care system. Among several imaging techniques developed to enhance melanoma diagnosis, optical coherence tomography (OCT), with its high-resolution and intermediate penetration depth, can potentially provide required diagnostic information noninvasively. Here, we present an image analysis algorithm, "optical properties extraction (OPE)," which improves the specificity and sensitivity of OCT by identifying unique optical radiomic signatures pertinent to melanoma detection. We evaluated the performance of the algorithm using several tissue-mimicking phantoms and then tested the OPE algorithm on 69 human subjects. Our data show that benign nevi and melanoma can be differentiated with 97% sensitivity and 98% specificity. These findings suggest that the adoption of OPE algorithm in the clinic can lead to improvements in melanoma diagnosis and patient experience. SIGNIFICANCE: This study describes a noninvasive, safe, simple-to-implement, and accurate method for the detection and differentiation of malignant melanoma versus benign nevi.

Indexed as

AlgorithmsModels, StatisticalPhantoms, ImagingHumansImage Processing, Computer-AssistedMelanomaTomography, Optical Coherence

Identifiers

PMID30777852
PMCPMC6836720
OpenAlexW2917624070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.